pharmaphorum’s Paul Tunnah spoke with Otsuka Pharmaceutical’s North America Pharmaceutical Business president and CEO Kabir Nath about the company’s innovative digital collaboration with Proteus and ...
The first ever ‘digital’ pill with a built-in sensor to track compliance has been approved by the FDA, 19 months after being rejected by the agency over safety concerns. Abilify MyCite combines Otsuka ...
TVB-009 (denosumab biosimilar) for treating postmenopausal osteoporosis in people aged 60 to 90 [TSID11807] None selected Not selected TBC Abilify MyCite for treating bipolar disorder 1 or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback